The World Council of Churches - Ecumenical Advocacy Alliance endorses a newly expanded collaboration on HIV between the Medicine Patent Pool and Gilead. On 4 October, the MPP announced a licence with Gilead Sciences for bictegravir, a new integrase inhibitor part of a once-daily, single-tablet HIV regimen currently filed for regulatory approval at the United States Food and Drug Administration and the European Union.
Observed on 15-22 October 2017, the World Council of Churches Ecumenical Advocacy Alliance invites churches around the world again to a Churches’ Week of Action on Food, an opportunity to pray, reflect and take action together, for food-justice across the globe.
“How can we work together, to share what it is in our hands, share the work that is before us? How can we empower one another, capacity-build our religious leaders and mobilize our congregations, to be more proactive in health-promoting issues?”
